Acasti Pharma Inc (NAS:ACST)
$ 3.2256 -0.009 (-0.28%) Market Cap: 30.32 Mil Enterprise Value: 5.23 Mil PE Ratio: 0 PB Ratio: 0.47 GF Score: 41/100

Q3 2020 Acasti Pharma Inc Earnings Call Transcript

Feb 14, 2020 / 06:00PM GMT
Release Date Price: $27.36 (-1.55%)
Operator

Ladies and gentlemen, hello, and thank you all for your patience and for joining today's Acasti Pharma Third Quarter 2020 Business Update Conference call. (Operator Instructions) Today's session is being recorded.

And with that, I am pleased to turn the floor over to Mr. David Waldman with Investor Relations. Welcome, David.

David K. Waldman
Crescendo Communications, LLC - President & CEO

Thank you. Good afternoon, everyone, and welcome to Acasti Pharma's Third Quarter Fiscal 2020 Conference Call. On the call with us this afternoon are: Jan D' Alvise, President and CEO; Pierre Lemieux, Chief Operating Officer, Chief Scientific Officer and Co-Founder; Brian Groch, Chief Commercial Officer; and Jean-François Boily, Vice President, Finance. If you have questions after the call or would like any additional information about the company, please contact Crescendo Communications at (212) 671-1020.

I'd also like to remind everyone that statements on this conference call that are not statements of historical or current fact constitute forward

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot